News
25 July 2019

EPAM Protects One of the Largest National Pharmaceutical Chains in the Rospatent Chamber for Patent Disputes

The national pharmaceutical chain VITA / VITA Express, which has been operating in Russia since 1995 and numbers 1,730 pharmacies, engaged the Firm’s services after it became known that a competitor was also using a logo containing the word “ВИТА” (the Russian word for VITA) and a similar colour combination on its signs. Moreover, VITA’s opponent managed to register its logo as a trademark with Rospatent. Protecting the client’s interests proved to be challenging as the logo used by the client was different from the one protected by their trademark.

25 June 2019

EPAM Successfully Defended Finnish Pharmaceutical Company Orion Corporation in a Patent Dispute

The Firm’s attorneys continue to successfully defend the patent rights of major international pharmaceutical companies. This is the fourth pharmaceutical manufacturer (along with Novartis, Bayer, and BMS) that successfully sought legal redress in the Intellectual Property Court thanks to the Firm’s team

30 November 2018

EPAM, Working With Tilling Peters, Leads Team to Victory in Bayer Patent Dispute

Associates from the Firm have continued their efforts to protect the patent rights of major international pharmaceutical firms, working with colleagues from Tilling Peters to secure a victory in the Intellectual Property Court for German multinational Bayer, overturning previous court rulings in the case.

2 September 2016

EPAM Ukraine Successfully Defended Interests of International Pharmaceutical Company in a Dispute on Patent Issues

EPAM Ukraine team successfully defended interests of one of the world's largest pharmaceutical companies in a dispute with the State Intellectual Property Service of Ukraine (Patent office) on extension of patent term for medical product for of additional 3 years over standard 20 years’ term.

11 January 2016

Key Appointments at EPAM

EPAM is pleased to announce new appointments: the Firm appoints Anna Numerova as Partner of Competition Practice in Moscow and Michael Copeland as a Partner in London. Further, Igor Schikow (Tax Practice), Alexey Andrusenko and Andrey Mashkovtsev (M&A and Corporate Practice), Roman Malovitsky (Banking & Finance, Capital Markets Practice) and Andrey Bashirov (Legislation and Public Policy Practice) have been appointed as Counsel in Moscow. Viktoriya Podvorchanska (Pharmaceuticals and healthcare), Arsen Miliutin (Domestic Litigation) and Oleksandr Maydanyk (Tax Practice) have been appointed as Counsel in Kyiv.

20 July 2012

EPAM successfully defends Sanofi Aventis in Russian libel case

EPAM has successfully protected the reputation of Sanofi Aventis, one of the world's largest pharmaceutical companies, during a complex libel case against several Russian publishing houses.

22 November 2011

EPAM successfully defends the IP rights for Russia’s leading pharmaceutical manufacturer

EPAM has successfully represented Antiviral, a Russian pharmaceutical manufacturer, whose products include Antigrippin-Maximum and Antigrippin-ANVI, in a dispute with Natur Produkt International, in regards to the Intellectual Property rights of Antigrippin trademarks.